<DOC>
	<DOCNO>NCT02721342</DOCNO>
	<brief_summary>Most chronic kidney disease progressive evolution characterize gradual loss glomerular filtration rate ( GFR ) , electrolytic imbalance , reduce erythropoietin synthesis activation vitamin D. On many occasion , progressive deterioration renal function occur , even etiologic factor responsible kidney disease treat and/or eliminate result auto-sustained mechanism inflammation fibrosis . Moreover , chronic nephropathy often associate high blood pressure increase urine protein excretion , risk factor progression toward kidney failure . Many clinical study show efficacy antihypertensive therapy , particularly blockade renin-angiotensin system , low abnormal urinary protein excretion . Moreover , control blood pressure proteinuria slow rate renal function decline case even lead recovery kidney function avoid need renal replacement therapy . The set measure achieve result encompass term `` renoprotective therapy '' . However achievement obtain set clinical trial , need confirmation daily clinical practice . To purpose standardized multidrug intervention model aim normalize excretion urinary protein stabilize renal function develop outpatient-clinic name `` Remission Clinic '' . The applicability protocol aim nephrology diabetology center . Through use dedicate database computer network , possible share clinical , laboratory treatment data , record patient enrol Remission Clinic program . With system , possible verify multidrug approach Remission Clinic allow improve clinical course chronic proteinuric nephropathy . All participant ( center ) may access Remission Clinic website develop , update maintain Department Bioengineering Mario Negri Institute , Bergamo , Italy .</brief_summary>
	<brief_title>Remission Clinic Proteinuric Chronic Nephropathies</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Ramipril</mesh_term>
	<mesh_term>Irbesartan</mesh_term>
	<criteria>Proteinuria &gt; 0.5 g/24 hour albuminuria &gt; 200 g / min ( &gt; 300 g/24 hour ) least 2 consecutive evaluation regardless treatment ACEi and/or ARBs ; Change serum creatinine creatinine clearance le 30 % last 3 month ; No corticosteroid immunosuppressant time inclusion give patient last 6 month . Idiopathic membranous nephropathy ; Focal segmental glomerulosclerosis ; Minimal change glomerulopathy ; Nephritic syndrome ; Rapidly progressive renal failure ( extracapillary glomerulonephritis active phase ) ; Any active renal disease represent possible indication corticosteroid immunosuppressive therapy ; Nephropathies secondary systemic disease susceptible treatment corticosteroid immunosuppressive agent ( Systemic Lupus Erythematosus , Vasculitis , Amyloidosis , etc . ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Chronic proteinuric nephropathy</keyword>
</DOC>